Among the challenges of living with HIV is a higher risk of fatty liver, a condition that can lead to chronic disease, a liver transplant or even death. Kristine Erlandson, MD, a University of Colorado Department of Medicine faculty member, has found that a medication used to treat diabetes and obesity – and touted on social media for weight loss – can be a powerful weapon against a type of fatty liver disease in people with HIV. Erlandson is an associate professor in the Division of Infectious Diseases. Her research is focused on helping people with the human immunodeficiency virus, or HIV, live longer lives despite the health challenges they often face.
Mark Harden
NBC News
CU Anschutz
Academic Office One
12631 East 17th Avenue
8601
Aurora, CO 80045